Eric P. Lefkofsky Sells 3,240,234 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 3,240,234 shares of the firm’s stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $58.75, for a total value of $190,363,747.50. Following the completion of the sale, the chief executive officer now directly owns 4,895,589 shares of the company’s stock, valued at approximately $287,615,853.75. The trade was a 39.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Tempus AI Stock Performance

Shares of Tempus AI stock opened at $55.30 on Friday. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The company has a 50 day moving average of $52.29 and a 200-day moving average of $52.27. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $91.45.

Institutional Investors Weigh In On Tempus AI

A number of large investors have recently modified their holdings of the business. Kovitz Investment Group Partners LLC bought a new position in Tempus AI in the third quarter valued at about $1,367,000. China Universal Asset Management Co. Ltd. bought a new position in Tempus AI in the 4th quarter valued at approximately $1,091,000. Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Tempus AI by 1,591.2% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after buying an additional 1,145,698 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Tempus AI during the fourth quarter worth $178,000. Finally, Captrust Financial Advisors bought a new position in shares of Tempus AI in the 3rd quarter valued at $2,726,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on TEM shares. Loop Capital reduced their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and upped their price target for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Guggenheim restated a “buy” rating on shares of Tempus AI in a research report on Tuesday. William Blair reaffirmed a “market perform” rating on shares of Tempus AI in a research report on Tuesday. Finally, Needham & Company LLC lifted their price target on Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a report on Tuesday. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $60.55.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.